These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3618627)

  • 1. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes.
    Osei K; Falko J; Bossetti BM; Holland GC
    Am J Med; 1987 Aug; 83(2):249-55. PubMed ID: 3618627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism.
    Osei K; Bossetti B
    Diabet Med; 1989 Aug; 6(6):506-11. PubMed ID: 2527132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
    Gumbiner B; Low CC; Reaven PD
    Diabetes Care; 1998 Jan; 21(1):9-15. PubMed ID: 9538963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
    Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
    J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans.
    Saunders JP; Donner TW; Sadler JH; Levin GV; Makris NG
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S57-65. PubMed ID: 10341162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus.
    Hughes TA; Gwynne JT; Switzer BR; Herbst C; White G
    Am J Med; 1984 Jul; 77(1):7-17. PubMed ID: 6377892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.
    Mughal MA; Memon MY; Zardari MK; Tanwani RK; Ali M
    J Pak Med Assoc; 2000 May; 50(5):152-6. PubMed ID: 11242714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose and insulin sensitivity in patients with type 2 diabetes.
    Koivisto VA; Yki-Järvinen H
    J Intern Med; 1993 Feb; 233(2):145-53. PubMed ID: 8433075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients.
    Harder H; Dinesen B; Astrup A
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):180-2. PubMed ID: 14610532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.
    Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM
    Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.
    Christiansen E; Schnider S; Palmvig B; Tauber-Lassen E; Pedersen O
    Diabetes Care; 1997 May; 20(5):881-7. PubMed ID: 9135961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fructose, xylitol, or sorbitol as a sweetener in diabetes mellitus.
    Brunzell JD
    Diabetes Care; 1978; 1(4):223-30. PubMed ID: 400132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus.
    Coulston AM; Hollenbeck CB; Swislocki AL; Chen YD; Reaven GM
    Am J Med; 1987 Feb; 82(2):213-20. PubMed ID: 3544839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid meal replacements and glycemic control in obese type 2 diabetes patients.
    Yip I; Go VL; DeShields S; Saltsman P; Bellman M; Thames G; Murray S; Wang HJ; Elashoff R; Heber D
    Obes Res; 2001 Nov; 9 Suppl 4():341S-347S. PubMed ID: 11707563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose as a dietary sweetener in diabetes mellitus.
    Koivisto VA
    Diabetes Care; 1978; 1(4):241-6. PubMed ID: 400134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and dietary determinants of serum lipids in obese patients with recently diagnosed non-insulin-dependent diabetes.
    Laitinen J; Uusitupa M; Ahola I; Siitonen O
    Ann Med; 1994 Apr; 26(2):119-24. PubMed ID: 8024729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and long-term effects of acute caloric deprivation in obese diabetic patients.
    Bauman WA; Schwartz E; Rose HG; Eisenstein HN; Johnson DW
    Am J Med; 1988 Jul; 85(1):38-46. PubMed ID: 3291612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
    Heilbronn LK; Noakes M; Clifton PM
    Diabetes Care; 1999 Jun; 22(6):889-95. PubMed ID: 10372237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.